美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

美國抗疫概念

1,769.01

-26.4741-1.47%

漲家數：4

跌家數：14

平家數：1

市盈率：- -

高：1,794.75

開：1,794.75

低：1,743.52

收：1,795.49

成交量：1.27億

成交額：79.29億

市值：1.44萬億

流通市值：1.42萬億

資料載入中...

奧托馬斬獲3200萬瑞典克朗訂單

美國食品藥品監督管理局批准雅培HIV Combo Next檢測試劑

Vaxart公布其口服新冠疫苗2B期臨床試驗400人哨兵安全隊列的12個月頂線安全性數據

阿斯利康(AZN)股票7月6日盤中下跌3.79%：投資者必看的核心信息

TradingKey中文

Aethlon Medical宣佈依據納斯達克規則完成400萬美元后續市場發行定價

滙豐將輝瑞目標股價從32美元下調至28美元，將評級從買入下調至持有。

Ortoma獲3200萬瑞典克朗訂單強生醫療科技訂購44套OTS髖關節系統

大行評級丨Baird：首予雅培「跑贏大市」評級及目標價121美元

石藥集團盤初漲近7% 石藥集團與阿斯利康達成17.7億美元新合作

世衞組織稱，剛果（金）啓動邦迪布吉奧埃博拉治療臨床試驗

阿斯利康漲幅擴大，觸及盤中高點，最新漲幅為6%。

阿斯利康(AZN)股票7月2日盤中上漲3.92%：真相來了

TradingKey中文

阿斯利康與石藥合作開發新型小核酸藥物

石藥創新(300765.SZ)子公司巨石生物與阿斯利康達成新型肝外遞送小干擾核酸創新藥物戰略合作

石藥集團稱與阿斯利康就開發SIRNA藥物訂立合作、選擇權及授權協議。

創新藥企攜手阿斯利康再達重磅國際合作！全市場僅有的恒生創新藥ETF華泰柏瑞連續9個交易日成交額突破10億

港股異動 | 和譽-B(02256)升逾5% 附屬與阿斯利康共同推進一項新型靶免聯合療法治療NSCLC臨床研究

和譽在港交所公告，公司之附屬公司和譽醫藥宣佈，與阿斯利康簽署戰略合作協議，共同推進一項新型靶免聯合療法治療非小細胞肺癌的

和譽-B(02256)附屬與阿斯利康達成戰略合作開展同類首創口服PD-L1抑制劑ABSK043聯合泰瑞沙®治療非小細胞肺癌的臨床研究

Vaxart與股東團體達成合作協議，宣佈董事會及公司治理結構優化

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1769.0146,"timestamp":1783367999999,"preClose":1795.4888,"halted":0,"volume":126821446,"delay":0,"changeRate":-0.014745,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-26.474121,"latestTime":"07-06 16:00:00 EDT","open":1794.7467,"high":1794.7467,"low":1743.5234,"amount":7929435327.700738,"amplitude":0.028529,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1783431000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.487557,"peRate":29.73735,"turnoverRate":0.009122,"increases":4,"decrements":14,"flats":1,"marketCap":1443344073371,"floatMarketCap":1420329237164},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1794.7467,"amplitude":0.028529,"preClose":1795.4888,"low":1743.5234,"pbRate":"4.487557","latestPrice":1769.0146,"volume":126821446,"delay":0,"open":1794.7467,"prevYearClose":1637.1339,"prevWeekClose":1795.4888,"prevMonthClose":1731.2963,"prevQuarterClose":1731.2963,"fiveDayClose":1741.7472,"twentyDayClose":1648.69,"sixtyDayClose":1789.0016,"secType":"PLATE","market":"US","turnoverRate":0.009122,"peRate":29.73735,"marketCap":1443344073371,"floatMarketCap":1420329237164,"timestamp":1783367999999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":4,"down":14,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1145675744","title":"奧托馬斬獲3200萬瑞典克朗訂單","url":"https://stock-news.laohu8.com/highlight/detail?id=1145675744","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145675744?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 16:52","pubTimestamp":1783414335,"startTime":"0","endTime":"0","summary":"奥托马公司近日宣布，其获得了强生医疗科技公司一份价值3200万瑞典克朗的订单。根据订单内容，强生医疗科技将采购44套奥托马髋关节系统，这些产品将销往欧洲、美国及日本市场。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU2750360997.AUD","LU2213496289.HKD","LU1244550494.USD","LU2023250330.USD","LU0889566641.SGD","IE0001KFT4U8.USD","LU1585245621.USD","IE00B4R5TH58.HKD","SG9999002232.USD","LU0820561818.USD","IE0002141913.USD","IE00BSNM7G36.USD","LU0114720955.EUR","IE00B19Z3581.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1280957306.USD","LU2456880835.USD","BK4550","LU2602419157.SGD","LU2896262040.SGD","LU0345770993.USD","LU1914381329.SGD","IE00BDGV0183.EUR","IE00BZ1G4Q59.USD","LU1057294990.SGD","IE00B3T34201.USD","LU0683600562.USD","LU1066051811.HKD","LU2089984988.USD","SGXZ57979304.SGD","LU0053666078.USD","SG9999002224.SGD","LU1983299246.USD","RXL","LU1074936037.SGD","LU2471134796.USD","PJP","IE00B2B36J28.USD","BK4559","IE00BLSP4452.SGD","IE000BZT7R73.USD","LU1043141123.HKD","IE0000B7K699.USD","LU2505996681.GBP","LU0289739699.SGD","FHLC","LU0426417589.USD","LU2468319806.SGD","LU2505996509.AUD","IE00B42XCP33.USD","LU0820562030.AUD","LU1551013425.SGD","LU2236285917.USD","BK4534","IE00BFXG1179.USD","LU0795875086.SGD","LU2756315664.SGD","LU0203347892.USD","IE000M9KFDE8.USD","LU1066051225.USD","LU2129689514.USD","LU2471134879.HKD","BK4532","LU0466842654.USD","IE00B7SZLL34.SGD","LU0070217475.USD","LU0432979614.USD","LU1718418525.SGD","SG9999001176.SGD","LU1929549753.HKD","LU1894683264.USD","LU0124676726.USD","BK4568","LU1496350502.SGD","LU1221951046.USD","LU2129689605.HKD","LU0545562505.USD","LU1121112475.USD","LU2430703178.SGD","LU0985320562.USD","LU0882574055.USD","BK4592","IE0034235303.USD","SG9999001440.SGD","LU2112291526.USD","VHT","LU0122379950.USD","LU0689472784.USD","LU2487616109.SGD","IYH","LU2133065610.SGD","IE00BVYPNV92.GBP","BMED","LU0203345920.USD","LU1244550221.USD","IE000SO60NU8.SGD","LU0943347566.SGD","LU1066051498.USD","LU1506573853.SGD","IE00BJJMRZ35.SGD","LU2756315318.SGD","FTXH","LU2403377893.USD","IE00BBT3K403.USD","XLV","LU1023059063.AUD","LU0234570918.USD","LU1032955483.USD","BK4585","LU1145028129.USD","LU1162221912.USD","IE000MB6IJN5.SGD","LU0795875169.SGD","LU1061106388.HKD","IE0002270589.USD","LU0058720904.USD","LU0210536198.USD","LU1674673691.USD","LU2129689431.USD","JDOC","LU0912757837.SGD","IE00BLSP4239.USD","LU1674673428.USD","GDOC","LU2592432038.USD","LU1629891620.HKD","IXJ","LU2347655156.SGD","LU0964807845.USD","IE00B1BXHZ80.USD","IE00BVYPNW00.USD","LU0640476718.USD","LU0426412945.USD","IHE","LU1430594728.SGD","LU1894683348.USD","LU1221951129.SGD","BK4581","LU1196500208.SGD","LU1244550577.SGD","SG9999013999.USD","LU2430703095.HKD","LU0787776722.HKD","LU2750360641.GBP","LU1228905540.USD","IE000WAW04H5.SGD","LU1261432733.SGD","LU2471134952.CNY","IE00BKVL7J92.USD","LU1778281490.HKD","BK4504","LU0098860793.USD","JNJ","IE0009355771.USD","LU0792757196.USD","LU0345770308.USD","LU1043141396.HKD","LU0820561909.HKD","LU1732800096.USD","LU0345769128.USD","LU0320765646.SGD","LU0689626769.HKD","LU1059921491.USD","SG9999001176.USD","LU0345769631.USD","LU0210528500.USD","LU2417539215.USD","IE00BN8TJ469.HKD","LU1732799900.SGD","LU0994945656.USD","IE000F7OJYX1.SGD","LU1267930813.SGD","LU1551013342.USD","LU1066053197.SGD","BK4588","LU2471134523.USD","IE00B19Z3B42.SGD","LU1032466523.USD","LU1935042991.SGD","IE00BGHQF631.EUR","LU2430703251.USD","LU1228905037.USD","BK4007","IE00BJT1NW94.SGD","MEDX","IE00B3PB1722.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187628046","title":"美國食品藥品監督管理局批准雅培HIV Combo Next檢測試劑","url":"https://stock-news.laohu8.com/highlight/detail?id=1187628046","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187628046?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 16:50","pubTimestamp":1783414233,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）于2026年6月29日，根据510(k)条款，批准了雅培公司（Abbott Laboratories）的HIV Combo Next检测试剂，其编号为BK261345。这一审批为雅培在传染病诊断领域的业务拓展提供了新的监管许可。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU1721429741.USD","PJP","LU1057294990.SGD","LU0058720904.USD","LU0266013472.USD","LU0122379950.USD","LU2089984988.USD","LU2112291526.USD","LU2211815571.USD","BK4533","IE0009355771.USD","LU2324357040.USD","LU1023059063.AUD","LU0114720955.EUR","BK4581","IE00BJT1NW94.SGD","LU0234572021.USD","IHI","IE00B2B36J28.USD","LU1989763690.USD","SG9999004303.SGD","BK4592","BK4588","LU0882574055.USD","SG9999002232.USD","IE0002141913.USD","SGXZ41872573.SGD","LU2237957902.USD","BK4566","LU1061106388.HKD","IE00BFTCPJ56.SGD","BK4504","BK4082","LU2237957811.SGD","LU1721429402.USD","LU0289739699.SGD","LU1691799644.USD","LU0170899867.USD","LU2133065610.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","SGXZ23171101.USD","LU1989763427.SGD","LU1914381329.SGD","LU0868494617.USD","ABT","IE00B4R5TH58.HKD","BK4585","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153971084","title":"Vaxart公布其口服新冠疫苗2B期臨床試驗400人哨兵安全隊列的12個月頂線安全性數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1153971084","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153971084?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:01","pubTimestamp":1783368106,"startTime":"0","endTime":"0","summary":"Vaxart, Inc. (VXRT) 公布了其口服片剂新冠疫苗在2B期临床试验中，针对400名参与者组成的哨兵安全队列所收集的12个月顶线安全性数据。该数据旨在评估疫苗在中期随访期内的安全性与耐受性概况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","VXRT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649620708","title":"阿斯利康(AZN)股票7月6日盤中下跌3.79%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2649620708","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649620708?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 23:15","pubTimestamp":1783350932,"startTime":"0","endTime":"0","summary":"• 阿斯利康与石药集团达成合作，交易总额高达17.7亿美元。\n• 受获利回吐、盈利预期修正以及监管管线不确定性影响，股价出现下跌。\n• Enhertu 获欧盟委员会批准用于治疗 HER2 阳性转移性实体瘤。","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262013535-market-movers-azn-20260706","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU2237443549.SGD","LU2237443622.USD","AZNH","LU2089984988.USD","LU2462157665.USD","LU1829250122.USD","LU2456880835.USD","BK4007","LU2237443978.SGD","LU2237443895.HKD","LU0889565916.HKD","LU0058720904.USD","LU0029864427.USD","LU0432979614.USD","LU2417539215.USD","LU0128525929.USD","LU0109394709.USD","LU2236285917.USD","BK4588","LU0310800379.SGD","LU2468319806.SGD","LU0289739699.SGD","LU0320765992.SGD","AZN","BK4585","LU2237443382.USD","BK4568","LU2237443465.HKD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150735355","title":"Aethlon Medical宣佈依據納斯達克規則完成400萬美元后續市場發行定價","url":"https://stock-news.laohu8.com/highlight/detail?id=1150735355","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150735355?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 21:29","pubTimestamp":1783344586,"startTime":"0","endTime":"0","summary":"Aethlon Medical宣布，已依据纳斯达克规则完成一笔总额400万美元的后续市场发行定价。此次发行严格遵循了市场定价机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","AEMD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649643195","title":"滙豐將輝瑞目標股價從32美元下調至28美元，將評級從買入下調至持有。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649643195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649643195?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 13:19","pubTimestamp":1783315199,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4568","LU0170899867.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","BK4533","SG9999002224.SGD","OZEM","LU0985481810.HKD","LU1066053197.SGD","BK4007","SG9999001176.USD","BK4599","SG9999013999.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0306807586.USD","SG9999002232.USD","BK4592","LU1023059063.AUD","LU0225284248.USD","LU0058720904.USD","IE00B3T34201.USD","BK4585","LU0868494617.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","SG9999001176.SGD","LU1894683264.USD","PFE","BK4534","IE0002270589.USD","LU0321505868.SGD","BK4581","LU1057294990.SGD","LU1894683348.USD","LU0321505439.SGD","SG9999003800.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU1066051498.USD","LU0306806265.USD","BK4588","LU0456855351.SGD","LU0122379950.USD","IE00BLSP4239.USD","LU0225771236.USD","LU2596442595.SGD","BK4550","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197788462","title":"Ortoma獲3200萬瑞典克朗訂單 強生醫療科技訂購44套OTS髖關節系統","url":"https://stock-news.laohu8.com/highlight/detail?id=1197788462","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197788462?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 17:33","pubTimestamp":1783071229,"startTime":"0","endTime":"0","summary":"Ortoma AB近日宣布，已获得一笔价值3200万瑞典克朗的订单。这笔订单来自强生旗下的医疗科技部门，内容为订购44套OTS髋关节系统，将供应至欧洲、美国及日本市场。\n该订单的签订，标志着Ortoma的核心产品在关键国际市场获得了重要客户的认可。OTS髋关节系统是Ortoma的旗舰产品之一，此次大规模采购将有助于提升其在全球骨科手术机器人领域的市场份额与影响力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","LU1718418525.SGD","IE00BLSP4239.USD","LU0795875086.SGD","LU1430594728.SGD","LU1066051225.USD","LU1280957306.USD","SG9999001440.SGD","LU2347655156.SGD","LU0820561818.USD","IE00B1BXHZ80.USD","LU1043141396.HKD","LU0234570918.USD","LU0943347566.SGD","LU1059921491.USD","BK4568","IE0002270589.USD","LU0432979614.USD","LU1221951129.SGD","IE00B42XCP33.USD","LU0053666078.USD","LU2471134952.CNY","LU1244550494.USD","LU0345769631.USD","LU1674673428.USD","LU1032466523.USD","LU1506573853.SGD","IE00BVYPNW00.USD","LU2505996681.GBP","IE00BZ1G4Q59.USD","LU1244550221.USD","LU0320765646.SGD","IE00BKVL7J92.USD","LU2133065610.SGD","LU0683600562.USD","LU0689472784.USD","LU1629891620.HKD","LU0820561909.HKD","IE00B2B36J28.USD","IE000BZT7R73.USD","IE00B3T34201.USD","JNJ","BK4559","SG9999001176.USD","LU2089984988.USD","LU2471134523.USD","IE00BLSP4452.SGD","LU2468319806.SGD","LU1228905037.USD","BK4588","LU0466842654.USD","LU1228905540.USD","LU2592432038.USD","LU2129689514.USD","LU1914381329.SGD","IE000M9KFDE8.USD","LU1894683264.USD","LU1551013425.SGD","IE0000B7K699.USD","LU0912757837.SGD","LU2430703095.HKD","LU1066053197.SGD","LU0210536198.USD","LU2417539215.USD","LU1066051811.HKD","IE00BN8TJ469.HKD","LU1244550577.SGD","LU1496350502.SGD","LU0820562030.AUD","LU0345769128.USD","BK4581","LU2456880835.USD","LU0203347892.USD","IE00BJT1NW94.SGD","LU1032955483.USD","IE0009355771.USD","LU1983299246.USD","LU1145028129.USD","LU2430703178.SGD","LU0345770993.USD","LU0787776722.HKD","LU1732800096.USD","LU2896262040.SGD","SG9999002232.USD","LU1732799900.SGD","LU1074936037.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1929549753.HKD","LU2602419157.SGD","BK4550","LU1267930813.SGD","LU1674673691.USD","LU0426417589.USD","LU0070217475.USD","LU1935042991.SGD","LU0640476718.USD","IE000WAW04H5.SGD","LU1023059063.AUD","BK4007","LU0985320562.USD","LU1894683348.USD","IE00BFXG1179.USD","LU2487616109.SGD","LU2750360997.AUD","SG9999001176.SGD","LU2750360641.GBP","LU2756315664.SGD","BK4532","LU0345770308.USD","LU2471134879.HKD","LU1061106388.HKD","LU2403377893.USD","LU2430703251.USD","IE00BBT3K403.USD","LU2213496289.HKD","IE00BDGV0183.EUR","LU0058720904.USD","LU0124676726.USD","LU2756315318.SGD","LU1261432733.SGD","IE0002141913.USD","BK4592","LU0426412945.USD","LU2505996509.AUD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","BK4533","LU1043141123.HKD","LU0994945656.USD","LU2471134796.USD","LU2112291526.USD","SG9999002224.SGD","LU2129689431.USD","IE000SO60NU8.SGD","LU1196500208.SGD","LU0203345920.USD","LU0882574055.USD","IE000MB6IJN5.SGD","LU1057294990.SGD","LU2236285917.USD","LU0210528500.USD","LU1066051498.USD","LU2023250330.USD","BK4534","LU0964807845.USD","LU0114720955.EUR","LU0098860793.USD","IE00BVYPNV92.GBP","LU1221951046.USD","IE00B19Z3B42.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU0689626769.HKD","LU1551013342.USD","BK4504","LU1121112475.USD","IE00BGHQF631.EUR","LU0122379950.USD","LU1778281490.HKD","LU0289739699.SGD","BK4585","IE00B19Z3581.USD","IE000F7OJYX1.SGD","LU0234572021.USD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0795875169.SGD","LU0889566641.SGD","LU0545562505.USD","LU2129689605.HKD","LU1162221912.USD","IE0001KFT4U8.USD","LU0792757196.USD","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648630439","title":"大行評級丨Baird：首予雅培「跑贏大市」評級及目標價121美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648630439","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648630439?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 11:23","pubTimestamp":1783049012,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2324357040.USD","IE0002141913.USD","LU0122379950.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0266013472.USD","SG9999004303.SGD","LU1057294990.SGD","LU1989763427.SGD","IE00BJJMRZ35.SGD","BK4568","SGXZ23171101.USD","LU0170899867.USD","LU1914381329.SGD","LU1989763690.USD","LU1061106388.HKD","LU0058720904.USD","LU2237957811.SGD","BK4566","BK4533","LU0882574055.USD","SG9999002232.USD","UDN","LU1721429741.USD","LU2237957902.USD","ABT","BK4581","LU2089984988.USD","LU1023059063.AUD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0234572021.USD","LU2468319806.SGD","LU2133065610.SGD","BK4082","SGXZ41872573.SGD","LU1721429402.USD","LU0289739699.SGD","LU1691799644.USD","LU2211815571.USD","BK4504","LU0114720955.EUR","LU0868494617.USD","SG9999002224.SGD","BK4585","UUP","BK4592","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648321696","title":"石藥集團盤初漲近7% 石藥集團與阿斯利康達成17.7億美元新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648321696","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648321696?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042860,"startTime":"0","endTime":"0","summary":"　　石药集团早盘涨近7%，截至发稿，股价上涨4.64%，现报7.90港元，成交额2.37亿港元。　　石药集团宣布，与阿斯利康达成小核酸药物合作。　　根据该协议的条款，石药集团与阿斯利康将针对两个靶点共同发现和开发具备治疗肾脏疾病多种适应症潜力的临床前候选药物。石药集团将保留其中一个 PCC 在中国境内开发、生产和商业化的全部权益。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-03/doc-inifntfa5634037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1951186391.HKD","01093","AZN","LU0432979614.USD","LU0314109678.HKD","BK4588","LU1993786604.SGD","LU0326950275.SGD","LU1807302812.USD","LU0708994859.HKD","IE0008368742.USD","IE00B031HY20.USD","LU0128525929.USD","LU0310800379.SGD","LU0058720904.USD","LU0501845795.SGD","LU1328277881.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","LU1829250122.USD","LU0889565916.HKD","LU2237443978.SGD","LU1226288253.USD","LU2237443465.HKD","IE00B3T34201.USD","IE00B543WZ88.USD","LU1813983027.USD","LU0029864427.USD","LU2089984988.USD","BK1191","LU1152091168.USD","LU0880133367.SGD","LU0072913022.USD","LU2456880835.USD","LU0315179316.USD","AZNH","LU1226288170.HKD","SG9999004220.SGD","BK4568","LU2236285917.USD","LU0109394709.USD","LU0289739699.SGD","BK1521","BK4585","LU2462157665.USD","LU2237443382.USD","IE00BZ08YS42.EUR","LU1152091754.HKD","IE00B5MMRT66.SGD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648689249","title":"世衞組織稱，剛果（金）啓動邦迪布吉奧埃博拉治療臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2648689249","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648689249?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 23:39","pubTimestamp":1783006747,"startTime":"0","endTime":"0","summary":"世卫组织称，刚果（金）启动邦迪布吉奥埃博拉治疗临床试验Mariam Sunny/Jennifer Rigby路透7月2日-世界卫生组织总干事特德罗斯·阿达诺姆·格布雷耶苏斯博士向记者表示，针对刚果民主共和国邦迪布吉奥埃博拉疫情的治疗试验于周四招募了首位患者，这标志着抗击疫情工作迈出了重要一步。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL4T4341AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","IE0002270589.USD","LU1037948897.HKD","LU2089984988.USD","LU1934455277.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU1778281490.HKD","IE00B7SZLL34.SGD","LU0234570918.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1934455194.USD","LU1057294990.SGD","LU0882574055.USD","BK4550","SG9999015978.USD","IE00B19Z3B42.SGD","GILD","BK4568","LU2468319806.SGD","LU0109394709.USD","BK4566","LU1061106388.HKD","SG9999015986.USD","LU1839511570.USD","LU1430594728.SGD","LU2087621335.USD","LU1674673428.USD","BK4578","IE00B19Z3581.USD","LU0114720955.EUR","LU1585245621.USD","LU0861579265.USD","BK4583","BK4139","LU0965509010.AUD","LU0889565916.HKD","LU1674673691.USD","LU0965508806.USD","LU1066051498.USD","LU2112291526.USD","IE00B3T34201.USD","LU1934455863.HKD","LU1037948541.HKD","LU0058720904.USD","LU0320765992.SGD","BK4585","SG9999015945.SGD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648686711","title":"阿斯利康漲幅擴大，觸及盤中高點，最新漲幅為6%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648686711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648686711?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 23:04","pubTimestamp":1783004682,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1267930573.SGD","LU0128525929.USD","IE00B3T34201.USD","AZNH","LU0310800379.SGD","LU2089984988.USD","LU2468319806.SGD","LU0029864427.USD","LU2237443978.SGD","BK4588","LU0109394709.USD","BK4007","LU0889565916.HKD","LU2236285917.USD","BK4568","LU0432979614.USD","LU2462157665.USD","LU0320765992.SGD","LU1829250122.USD","LU2237443549.SGD","LU2237443895.HKD","LU2417539215.USD","LU2237443622.USD","AZN","LU0289739699.SGD","BK4585","LU2456880835.USD","LU0058720904.USD","LU2237443382.USD","LU0708994859.HKD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648685077","title":"阿斯利康(AZN)股票7月2日盤中上漲3.92%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685077","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648685077?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 22:16","pubTimestamp":1783001771,"startTime":"0","endTime":"0","summary":"• 阿斯利康与石药集团达成合作，交易总额高达17.7亿美元。\n• 肿瘤领域的新合作以及欧盟的监管进展巩固了该公司的研发管线并提振了股价。\n• 在美国劳动力市场数据降温的背景下，该股从近期临床试验失败的阴霾中反弹。","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262007437-market-movers-azn-20260702","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","LU0058720904.USD","LU0128525929.USD","LU2237443622.USD","LU2456880835.USD","LU2468319806.SGD","AZN","LU2236285917.USD","LU0320765992.SGD","BK4007","LU0708994859.HKD","LU0109394709.USD","BK4568","BK4588","LU1829250122.USD","LU2237443465.HKD","LU2237443382.USD","AZNH","LU0889565916.HKD","LU1267930573.SGD","LU2237443895.HKD","LU0289739699.SGD","BK4585","LU0432979614.USD","IE00B3T34201.USD","LU2237443978.SGD","LU2089984988.USD","LU2462157665.USD","LU2417539215.USD","LU0029864427.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648506369","title":"阿斯利康與石藥合作開發新型小核酸藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2648506369","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648506369?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 17:49","pubTimestamp":1782985786,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4568","LU0708994859.HKD","LU0432979614.USD","LU2417539215.USD","LU0320765992.SGD","LU1829250122.USD","LU0128525929.USD","LU2456880835.USD","LU2237443978.SGD","LU0058720904.USD","LU2236285917.USD","LU0289739699.SGD","LU0889565916.HKD","BK4007","BK4585","LU2462157665.USD","LU2237443895.HKD","LU2237443622.USD","IE00B3T34201.USD","BK4588","AZN","LU1267930573.SGD","LU2237443465.HKD","AZNH","LU0029864427.USD","LU2468319806.SGD","LU2237443549.SGD","LU0109394709.USD","LU0310800379.SGD","LU2089984988.USD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648503310","title":"石藥創新(300765.SZ)子公司巨石生物與阿斯利康達成新型肝外遞送小干擾核酸創新藥物戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648503310","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648503310?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 16:53","pubTimestamp":1782982410,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药创新 发布公告，公司的控股子公司石药集团巨石生物制药有限公司与阿斯利康于2026年7月1日签署《合作、选择权及授权协议》，将与阿斯利康在新型小干扰核酸候选药物领域开展战略合作，开发新型肝外递送小干扰分子核酸候选药物。阿斯利康将向巨石生物支付首付款3,000万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1267930573.SGD","LU0320765992.SGD","LU2468319806.SGD","LU0109394709.USD","LU2089984988.USD","BK4568","LU0029864427.USD","300765","159992","AZN","LU0708994859.HKD","LU2237443465.HKD","LU2237443622.USD","BK4007","LU2462157665.USD","BK4588","BK0226","LU2417539215.USD","06978","LU0310800379.SGD","LU2237443978.SGD","BK1161","LU2236285917.USD","LU2237443895.HKD","BK1574","LU0058720904.USD","LU2237443382.USD","LU0128525929.USD","LU1829250122.USD","AZNH","LU2456880835.USD","LU0432979614.USD","LU2237443549.SGD","LU0289739699.SGD","LU0889565916.HKD","BK4585","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648508319","title":"石藥集團稱與阿斯利康就開發SIRNA藥物訂立合作、 選擇權及授權協議。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648508319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648508319?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 16:32","pubTimestamp":1782981130,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AZNH","LU2468319806.SGD","LU2237443978.SGD","LU0310800379.SGD","LU0320765992.SGD","LU2236285917.USD","LU0128525929.USD","LU2237443382.USD","LU1829250122.USD","BK4007","IE00B3T34201.USD","LU0289739699.SGD","LU2417539215.USD","LU2237443895.HKD","LU2237443549.SGD","BK4568","LU0109394709.USD","LU0029864427.USD","LU2462157665.USD","LU2237443465.HKD","LU2237443622.USD","LU0058720904.USD","LU0432979614.USD","LU0708994859.HKD","LU1267930573.SGD","BK4588","LU0889565916.HKD","BK4585","LU2456880835.USD","AZN","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648579477","title":"創新藥企攜手阿斯利康再達重磅國際合作！全市場僅有的恒生創新藥ETF華泰柏瑞連續9個交易日成交額突破10億","url":"https://stock-news.laohu8.com/highlight/detail?id=2648579477","media":"新浪基金","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648579477?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 13:17","pubTimestamp":1782969420,"startTime":"0","endTime":"0","summary":"某港股龙头药企发布公告，旗下子公司与阿斯利康达成战略合作，双方将携手开展新型靶免联合疗法用于非小细胞肺癌的临床试验，这一合作再度引发市场对国产创新药板块的关注。　　目前市场上仅有的跟踪恒生创新药指数的ETF——恒生创新药ETF华泰柏瑞交投热度居高不下，产品已连续9个交易日单日成交额突破10亿元，本周一更是达27.64亿元，创下今年4月3日之后阶段新高，最新规模24.48亿元，场内流动性表现较亮眼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-07-02/doc-inifkuqa2716838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2468319806.SGD","LU2237443549.SGD","LU0320765992.SGD","LU0289739699.SGD","LU2417539215.USD","LU0109394709.USD","BK4588","LU1267930573.SGD","BK4007","LU0432979614.USD","IE00B3T34201.USD","LU0128525929.USD","520500","BK4585","159992","LU0058720904.USD","LU0889565916.HKD","LU2237443382.USD","LU2237443978.SGD","BK4568","LU0310800379.SGD","LU2237443895.HKD","LU0029864427.USD","AZNH","LU2456880835.USD","LU2237443622.USD","LU2089984988.USD","LU2462157665.USD","LU2236285917.USD","LU1829250122.USD","BK1161","BK1574","LU0708994859.HKD","06978","AZN","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648357688","title":"港股異動 | 和譽-B(02256)升逾5% 附屬與阿斯利康共同推進一項新型靶免聯合療法治療NSCLC臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2648357688","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648357688?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 11:32","pubTimestamp":1782963123,"startTime":"0","endTime":"0","summary":"消息面上，7月2日，和誉-B发布公告，本公司的附属公司上海和誉生物医药科技有限公司宣布，与阿斯利康签署战略合作协议，共同推进一项新型靶免联合疗法治疗非小细胞肺癌的临床研究。该研究的新药临床试验申请已于2026年5月20日获得国家药品监督管理局批准，本项II期研究由和誉医药主导，和誉医药和阿斯利康将共同承担该临床试验的相关职责。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","VXUS","LU2237443895.HKD","LU2476274720.SGD","LU0320765992.SGD","LU1267930573.SGD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU2237443978.SGD","LU2468319806.SGD","LU2417539215.USD","LU0310800379.SGD","LU2456880835.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0029864427.USD","BK4588","BK4585","LU0289739699.SGD","LU2237443465.HKD","LU2237443382.USD","LU2462157665.USD","BK4007","LU2236285917.USD","LU0058720904.USD","LU0128525929.USD","BK1161","LU2476274308.USD","AZN","LU2488822045.USD","LU2237443549.SGD","LU2237443622.USD","LU0432979614.USD","LU2089984988.USD","AZNH","LU1829250122.USD","LU0708994859.HKD","IE00B543WZ88.USD","LU2778985437.USD","LU0109394709.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648152730","title":"和譽在港交所公告，公司之附屬公司和譽醫藥宣佈，與阿斯利康簽署戰略合作協議，共同推進一項新型靶免聯合療法治療非小細胞肺癌的","url":"https://stock-news.laohu8.com/highlight/detail?id=2648152730","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648152730?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 08:16","pubTimestamp":1782951413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AZN","BK4007","LU2237443465.HKD","BK4568","LU2237443382.USD","LU0708994859.HKD","LU0432979614.USD","LU0029864427.USD","LU0889565916.HKD","LU0310800379.SGD","LU0289739699.SGD","LU0109394709.USD","LU2237443978.SGD","LU2468319806.SGD","LU2456880835.USD","LU1829250122.USD","LU2237443895.HKD","LU1267930573.SGD","AZNH","LU0058720904.USD","LU0128525929.USD","LU2089984988.USD","IE00B3T34201.USD","LU2236285917.USD","LU0320765992.SGD","LU2417539215.USD","LU2462157665.USD","BK4588","LU2237443549.SGD","BK4585","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648220025","title":"和譽-B(02256)附屬與阿斯利康達成戰略合作開展同類首創口服PD-L1抑制劑ABSK043聯合泰瑞沙®治療非小細胞肺癌的臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2648220025","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648220025?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 08:06","pubTimestamp":1782950774,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B 发布公告，本公司的附属公司上海和誉生物医药科技有限公司宣布，与阿斯利康签署战略合作协议，共同推进一项新型靶免联合疗法治疗非小细胞肺癌的临床研究。该联合研究是一项多中心、开放的I/II期临床试验，旨在评估和誉医药自主研发的同类首创口服小分子PD-L1抑制剂 ABSK043联合阿斯利康第三代EGFR-TKI泰瑞沙 ，用于治疗EGFR突变合并PD-L1阳性的局部晚期或转移性NSCLC患者中的安全性和疗效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AZNH","LU2237443465.HKD","IE00B543WZ88.USD","LU2237443895.HKD","AZN","LU2456880835.USD","BK4588","LU0320765992.SGD","LU0708994859.HKD","LU2237443978.SGD","LU2236285917.USD","LU0128525929.USD","LU1829250122.USD","BK4585","LU2237443382.USD","LU0310800379.SGD","BK4007","BK4023","02256","LU2237443622.USD","BK4568","LU0109394709.USD","BK1161","LU2417539215.USD","LU2237443549.SGD","PD","LU2462157665.USD","LU2476274308.USD","LU2476274720.SGD","LU2778985437.USD","IE00B3T34201.USD","LU2468319806.SGD","IE00B5MMRT66.SGD","LU0289739699.SGD","LU0029864427.USD","LU0432979614.USD","LU1169589451.USD","LU2488822045.USD","LU2089984988.USD","LU0889565916.HKD","LU0058720904.USD","LU1169590202.USD","LU1267930573.SGD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157672691","title":"Vaxart與股東團體達成合作協議，宣佈董事會及公司治理結構優化","url":"https://stock-news.laohu8.com/highlight/detail?id=1157672691","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157672691?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 04:07","pubTimestamp":1782936446,"startTime":"0","endTime":"0","summary":"Vaxart, Inc. 已与一个股东团体签署了合作协议，并宣布了一系列旨在加强董事会职能与公司治理水平的举措。此举标志着公司在回应股东关切、提升治理透明度方面迈出了重要一步。相关安排预计将优化董事会构成，并引入更符合股东利益的治理框架，以支持公司的长期战略发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","VXRT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}